Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Non-Current Assets (2016 - 2025)

CorMedix has reported Other Non-Current Assets over the past 15 years, most recently at $642066.0 for Q2 2025.

  • Quarterly results put Other Non-Current Assets at $642066.0 for Q2 2025, up 514.85% from a year ago — trailing twelve months through Jun 2025 was $642066.0 (up 514.85% YoY), and the annual figure for FY2024 was $105368.0, up 36.84%.
  • Other Non-Current Assets reached $642066.0 in Q2 2025 per CRMD's latest filing, roughly flat from $642066.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $642066.0 in Q1 2025 and bottomed at $77000.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $103251.0 (2023), compared with a mean of $164763.2.
  • The largest annual shift saw Other Non-Current Assets crashed 79.57% in 2021 before it soared 518.33% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $102305.0 in 2021, then rose by 21.21% to $124000.0 in 2022, then crashed by 37.9% to $77000.0 in 2023, then skyrocketed by 36.84% to $105368.0 in 2024, then soared by 509.36% to $642066.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CRMD at $642066.0 in Q2 2025, $642066.0 in Q1 2025, and $105368.0 in Q4 2024.